Exhibit 99.2

AMICAS, INC. AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

     On April 2, 2009, AMICAS, Inc. (“AMICAS”) completed its acquisition of Emageon Inc (“Emageon”). AMICAS acquired all of the outstanding shares of common stock of Emageon, at a price of $1.82 per share in cash. For the purpose of these unaudited pro forma condensed combined financial statements, the acquisition is assumed to have occurred as of January 1, 2008 with respect to the unaudited pro forma condensed combined statements of operations and as of March 31, 2009 with respect to the unaudited pro forma condensed combined balance sheet.

     The pro forma adjustments related to the acquisition are based on a preliminary purchase price allocation in accordance with Statement of Financial Accounting Standards No. 141(R) “Business Combinations” whereby the cost to acquire Emageon was allocated to the assets acquired and the liabilities assumed, based upon their estimated fair values. Actual adjustments will be based on the final purchase price and analyses of fair values of identifiable tangible and intangible assets and liabilities, and estimates of the useful lives of tangible and intangible assets, which will be completed after AMICAS completes its valuation and assessment process using all available data. The final purchase price allocation will be performed using estimated fair values as of the date of the acquisition. Differences between the preliminary and final purchase price allocations could have a material impact on the accompanying unaudited pro forma condensed combined financial statements and the future results of operations and financial position of AMICAS and subsidiaries.

     The unaudited pro forma condensed combined financial statements do not reflect the realization of any potential cost savings, or any related integration costs. Although AMICAS believes that certain cost savings may result from the acquisition, there can be no assurance that these cost savings will be achieved.

     The unaudited pro forma condensed combined financial statements are presented for illustrative purposes only and are not necessarily indicative of the consolidated financial position or results of operations in future periods or the results that actually would have been realized if the acquisition had been completed as of the dates indicated. As a result, the actual financial condition and results of operations of AMICAS following the acquisition may not be consistent with, or evident from, these pro forma financial statements. In addition, the assumptions used in preparing the pro forma financial information may not prove to be accurate, and other factors may affect AMICAS’s, financial condition or results of operations following the acquisition.

     For purposes of presenting the financial information, the historical financial information of AMICAS and Emageon is based on the year ended December 31, 2008 and the three months ended March 31, 2009.

     The financial information and accompanying notes should be read in conjunction with the historical consolidated financial statements and notes thereto of AMICAS included in our Annual Report on Form 10-K for the year ended December 31, 2008 and our previously filed Form 8-K, as well as the historical financial statements and notes thereto of Emageon included in its annual report on Form 10-K for the year ended December 31, 2008.

AMICAS, Inc. and subsidiaries
Unaudited Pro Forma Consolidated Combined Balance Sheet

March 31, 2009

												Pro Forma
	AMICAS, Inc.			Emageon Inc.			Pro Forma					Total
	(unaudited)			(unaudited)			Adjustments					(unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	44,076		$	18,345		$	(39,043	)	(A	)	$	23,378
Marketable securities		12,502			—								12,502
Accounts receivable, less allowance		9,654			11,288			593		(B	)		21,535
Inventories, net		—			4,047			(2,042	)	(C	)		2,005
Prepaid expenses and other current assets		2,671			4,436								7,107
TOTAL CURRENT ASSETS		68,903			38,116								66,527
Property and equipment, net		863			10,940			(817	)	(D	)		10,986
Goodwill		—			—			684		(E	)		684
Acquired/developed software		5,233			230			4,770		(E	)		10,233
Customer relationships		—			3,290			810		(E	)		4,100
Trademarks/tradenames		1,224			—			400		(E	)		1,624
Non compete		—			—			500		(E	)		500
Other assets		1,747			2,312			(500	)	(F	)		3,559
TOTAL ASSETS	$	77,970		$	54,888							$	98,213
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	4,375		$	7,923		$	(276	)	(G	)	$	12,022
Accrued employee compensation and benefits		1,252			1,704			517		(H	)		3,473
Deferred revenue, net of long-term portion		15,551			18,826			(9,306	)	(G	)		25,071
TOTAL CURRENT LIABILITIES		21,178			28,453								40,566
Deferred revenue, long-term portion		930			2,245			(1,665	)	(G	)		1,510
Other long-term liabilities		—			275								275
Unrecognized tax benefits		1,406			—								1,406
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS EQUITY
Preferred stock		—			—								—
Common stock		51			22			(22	)	(I	)		51
Additional paid-in capital		231,477			130,632			(130,632	)	(I	)		231,477
Accumulated deficit		(129,717	)		(107,698	)		107,698		(I	)		(129,717	)
Accumulated other comprehensive income (loss):		(2	)		730			(730	)	(I	)		(2	)
Treasury stock		(47,353	)		(271	)		271		(I	)		(47,353	)
TOTAL STOCKHOLDERS EQUITY		54,456			23,415								54,456
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	77,970		$	54,888							$	98,213

The accompanying notes are an integral part of the unaudited pro forma condensed combined financial
statements.

AMICAS, Inc. and subsidiaries
Unaudited Pro Forma Consolidated Statement of Operations
For the Year Ended December 31, 2008

												Pro Forma
												Total
							Acquisition					12/31/2008
	AMICAS, Inc.			Emageon Inc.			Adjustments					(unaudited)
Revenues	$	50,353		$	69,328							$	119,681
Operating Expenses
Cost of revenues		24,679			39,092			(893	)	(J	)		62,878
Selling, general, and administrative expenses		20,512			24,916								45,428
Research and development		8,657			17,170								25,827
Depreciation and amortization		1,084			3,775			(1,904	)	(J	)		2,955
Other operating expenses		—			5,547								5,547
Impairment of goodwill		27,313			21,577								48,890
Impairment of other intangibles		177			—								177
Total operating expenses		82,422			112,077								191,702
Operating loss		(32,069	)		(42,749	)							(72,021	)
Interest income		2,187			518			(1,308	)	(L	)		1,397
Interest expense		—			(40	)							(40	)
Loss on sale of investments		(31	)		—								(31	)
Loss before provision for income taxes		(29,913	)		(42,271	)							(72,695	)
Provision for income taxes		158			—								158
Net loss	$	(30,071	)	$	(42,271	)						$	(70,853	)
Basic loss per share	$	(0.77	)									$	(1.82	)
Diluted loss per share	$	(0.77	)									$	(1.82	)
Weighted average shares outstanding — basic		38,482											38,482
Weighted average shares outstanding — diluted		38,482											38,482

The accompanying notes are an integral part of the unaudited pro forma condensed combined financial
statements.

AMICAS, Inc. and subsidiaries
Unaudited Pro Forma Consolidated Statement of Operations
For the Three Months Ended March 31, 2009

												Pro Forma
												Total
	AMICAS, Inc.			Emageon Inc.			Acquisition					3/31/2009
	(unaudited)			(unaudited)			Adjustments					(unaudited)
Revenues	$	11,271		$	17,026							$	28,297
Operating Expenses
Cost of revenues		5,292			9,187			85		(J	)		14,564
Selling, general, and administrative expenses		4,521			5,713								10,234
Research and development		2,286			3,517								5,803
Depreciation and amortization		185			747			(308	)	(J	)		624
Acquisition related and integration costs		549			—								549
Other operating expenses		—			7,310			(6,869	)	(K	)		441
Total operating expenses		12,833			26,474								32,215
Operating loss		(1,562	)		(9,448	)							(3,918	)
Interest income, net		447			45			(313	)	(L	)		179
Loss before provision for income taxes		(1,115	)		(9,403	)							(3,739	)
Provision for income taxes		53			—								53
Loss before extraordinary item		(1,168	)		(9,403	)							(3,792	)
Extraordinary income		—			9,000								9,000
Net loss	$	(1,168	)	$	(403	)						$	5,208
Basic loss per share	$	(0.03	)									$	0.15
Diluted loss per share	$	(0.03	)									$	0.15
Weighted average shares outstanding — basic		35,195											35,195
Weighted average shares outstanding — diluted		35,195											35,195

The accompanying notes are an integral part of the unaudited pro forma condensed combined financial
statements.

AMICAS, Inc. and subsidiaries

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

(1) Basis of Pro Forma Presentation

The unaudited pro forma condensed combined financial statements are based on the historical financial statements of AMICAS and Emageon after giving effect to the acquisition of Emageon and the assumptions and adjustments described in the accompanying notes to the unaudited pro forma condensed combined financial statements. AMICAS acquired all of the outstanding shares of Emageon and the transaction closed on April 2, 2009. The accompanying unaudited condensed combined balance sheet assumes the acquisition of Emageon occurred on March 31, 2009.

(2) Purchase Price Allocation

AMICAS acquired all of the outstanding shares of Emageon, a publicly held company based in Birmingham, Alabama. Under the terms of the merger agreement, Emageon stockholders received $1.82 per share in cash for each Emageon share.

This acquisition has been accounted for as a business combination in accordance with SFAS 141(R), “Business Combinations”. The total purchase price of approximately $39.0 million was paid in cash:

Purchase Price Allocation

The allocation of the total purchase price to Emageon’s net tangible and identifiable intangible assets was based on their estimated fair values as of April 2, 2009. The excess of the purchase price over the identifiable intangible and net tangible assets was allocated to goodwill. The total purchase price of approximately $39.0 million has been allocated as follows (in thousands):

Goodwill	$	684
Intangible assets		10,000
Deferred revenue at fair value		(10,100	)
Property and equipment at fair value		10,123
Tangible assets acquired and liabilities assumed:
Cash and cash equivalents		18,345
Other current assets		18,322
Non-current assets		1,812
Accounts payable and current liabilities		(9,868	)
Other long-term liabilities		(275	)
Total purchase price		39,043

The fair value of certain identified intangible assets are based upon preliminary estimates and are subject to change which could be material. The following are preliminary intangible assets acquired and their respective amortizable lives (in thousands):

			Amortizable
Asset	Amount		life (years)
Customer relationships	$	4,100		9
Acquired technology		5,000		7
Tradenames		400		8
Non competes		500		9

(3) Pro Forma Adjustments

The following describes the pro forma adjustments made to the accompanying unaudited pro forma condensed combined financial statements:

A.	To give effect to cash payment of approximately $39.0 million to acquire the shares of Emageon Inc.
B.	Adjustment to record the excess of future billings above and beyond the estimated fair value of deferred revenue.
C.	Adjustment to eliminate accumulated deferred costs associated with deferred revenue. These accumulated costs are being eliminated because they do not reflect an asset of AMICAS.
D.	Adjustment to record the fair value of property, plant and equipment.
E.	Adjustment to reflect the preliminary estimate of the fair value of amortizable intangible assets, and goodwill. Identified amortizable intangible assets include acquired software technology, customer relationships, trade names and non-compete agreements. The Company has assumed straight-line amortization periods ranging from 84 months to 108 months based on the estimated useful lives of the intangible assets.
F.	To reduce investment in subsidiary to fair value.
G.	To adjust deferred revenue to fair value and to eliminate an associated accrued liability.
H.	To adjust accrued commissions and accrued vacation liabilities to fair value.
I.	To eliminate shareholders equity of Emageon Inc. as of the acquisition date.
J.	Reduction of depreciation and amortization expense as a result of the adjustment of property, plant and equipment and intangibles to fair value.
K.	To eliminate the nonrecurring expenses related to Emageon’s Strategic Alternative Committee expenses related to the AMICAS acquisition.
L.	Adjustment to record foregone interest income earned on available cash and marketable securities used for the acquisition.

(4) Notes to historical Emageon financial statements

1.	Other operating expenses in the twelve months ended December 31, 2008 include $3,243 thousand of nonrecurring expenses incurred by the Strategic Alternative Committee related to the unsuccessful acquisition of Emageon.
2.	Impairment of goodwill in the twelve months ended December 31, 2008 includes $21.6 million related to Emageon Inc.
3.	Extraordinary income in the 3 months ended March 31, 2009 includes $9,000 thousand of extra-ordinary income from the break-up payment made by the unsuccessful acquirer of Emageon Inc.